An assessment of the value of biochemical fetoplacental function tests in detecting intrauterine growth retardation.
Four serum biochemical fetoplacental function tests (HPL, unconjugated and total oestriol and AFP) were used to screen for intrauterine growth retardation in 793 patients attending an antenatal clinic. The birthweight corrected for sex, birth ranking and maternal size was used as an index of growth. The sensitivity and specificity of each test was calculated at varying cut-off points and plotted as 'Receiver Operator Curves'. HPL is clearly better than the oestriols or AFP with 80% sensitivity in detecting birth weights of less than the 5th centile when the 25th HPL centile is used as the cut-off point. However, the sensitivity of HPL is sufficiently low to make the value of screening questionable, particularly since 40% of all growth retarded infants were in mothers who did not attend antenatal clinic for screening and 25% of all growth retarded infants were detected by clinical examination.
McDowell
B
B
Clinical Chemistry Department, Birmingham Maternity Hospital, Edgbaston, UK.
Evans
S E
SE
Weaver
J B
JB
Little
D
D
D005260:Female; D005317:Fetal Growth Retardation / Q000175:diagnosis* / Q000378:metabolism; D005865:Gestational Age; D006801:Humans; D010925:Placental Function Tests; D011247:Pregnancy